Biotech Values

[DewDiligence]

NANOV.OL reverse-merges with Thor Medical:

https://www.nordicnanovector.com/investors-and-media/press-releases

Thor Medical, based in Oslo, Norway, is a private company that has developed a proprietary technology for the manufacturing of radionuclides, primarily alpha-particle emitters from natural resources. The high energy deposition and the short range of alpha particles make it possible to eradicate cancer cells while minimising damage to nearby healthy cells. Thor Medical will supply alpha emitters to radiopharmaceutical companies for the development of innovative, tumour-targeted cancer therapies.

This deal is being billed as a merger of equals, but the surviving programs will be exclusively those from Thor, and hence this is a reverse-merger for all practical purposes.

This is NANOV.OV’s second attempt at a reverse-merger; the first attempt failed when shareholders rejected the deal (#msg-170660145).